HimalayasHimalayas logo
Summit TherapeuticsST

Associate Director, Biostatistics

Summit Therapeutics is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel therapies to treat cancer, with its lead candidate ivonescimab undergoing multiple Phase 3 clinical trials.

Summit Therapeutics

Employee count: 201-500

Salary: 190k-210k USD

United States only

Stay safe on Himalayas

Never send money to companies. Jobs on Himalayas will never require payment from applicants.

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

  • HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

  • HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

  • HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

  • HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role:

Serves as the study-level biostatistician including reviewing protocol, conducting sample size calculations, developing statistical analysis plan, data presentation plan, and Data Monitoring Committee (DMC) charter, reviewing study documents (e.g., CRFs, ADaM specifications, statistical outputs, etc.) for clinical trials in oncology. Partners with cross-functional team members in ensuring accuracy/consistency of clinical data and exceptional delivery, interpretation of clinical results, and assists in the development and review of regulatory submission documents. Implements biostatistics department policies, standards, procedures, and work instructions.

Role and Responsibilities:

  • Provide statistical support to clinical development through the conduct of clinical studies in oncology
  • Conduct sample size calculations and develop statistical analysis plans (SAPs), data presentation plans, and DMC charters.
  • Collaborate with clinical operations, data management and CRO to develop and implement CRFs, database design, and the overall data quality plan
  • Review study documents (e.g., protocol, vendor data transfer specifications, ADaM specifications, statistical outputs) for clinical trials in oncology.
  • Review the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports
  • Contribute to the preparation of manuscripts for publication, ensuring accurate statistical reporting of research findings.
  • Develop and implement new statistical methodologies that enhance study design and analysis
  • Reviews and analyzes safety reporting, biomarker analyses and other aspects of clinical trial monitoring.
  • Independently defines required resources for assigned work, seeking advice as needed.
  • Work with department leader to develop and implement department policies, standards and procedures
  • Adheres to regulatory requirements of study conduct, statistical analysis principles, industry standards, and company SOPs.

Experience, Education and Specialized Knowledge and Skills:

  • Ph.D. in Statistics, Biostatistics or equivalent area with 6+ years biopharmaceutical industry experience required. MS degree in related discipline with extensive industry and leadership experience (8+ years) can be considered.
  • Strong proficiencies in software and other tools typically used by Biostatistics (e.g. SAS, R)
  • Good understanding of clinical trial processes and statistical programming requirements
  • Working knowledge of ICH, FDA and GCP regulations and guidelines
  • Attention to detail, accuracy and confidentiality
  • Clear and concise oral and written communication skills
  • Must be able to effectively multi-task and manage time-sensitive and highly confidential documents.
  • Communicate effectively and articulate complex ideas in an easily understandable way
  • Work in a fast-paced, demanding and collaborative environment

This is the pay for this position

Pay Transparency
$190,000—$210,000 USD

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

About the job

Apply before

Posted on

Job type

Full Time

Experience level

Salary

Salary: 190k-210k USD

Education

Postgraduate degree

Experience

6 years minimum

Experience accepted in place of education

Location requirements

Hiring timezones

United States +/- 0 hours

About Summit Therapeutics

Learn more about Summit Therapeutics and their company culture.

View company profile

Summit Therapeutics Inc. is a biopharmaceutical oncology company committed to the discovery, development, and commercialization of patient-, physician-, caregiver-, and societal-friendly medicinal therapies. The company's mission focuses on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs, particularly in the field of oncology.

Headquartered in Miami, Florida, with additional offices in Palo Alto, California; Princeton, New Jersey; Oxford, UK; and Dublin, Ireland, Summit Therapeutics has positioned itself as a leader in cancer treatment innovation. The company's lead pipeline candidate is ivonescimab, a novel bispecific antibody targeting both PD-1 and VEGF. In January 2023, Summit established a collaboration and license agreement with Akeso, Inc. for ivonescimab, gaining rights to develop and commercialize the therapy in the United States, Canada, Europe, Japan, Latin America, the Middle East, and Africa.

Summit is currently conducting multiple global Phase 3 clinical trials for ivonescimab, including studies in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company has initiated several Phase 3 trials including HARMONi, HARMONi-3, HARMONi-7, and HARMONi-GI3, demonstrating a commitment to advancing oncology treatment options. With a leadership team that has a proven track record in drug development, regulatory approval, and commercialization, Summit is positioning itself for durable growth while maintaining its focus on patient-centered innovation.

Employee benefits

Learn about the employee benefits and perks provided at Summit Therapeutics.

View benefits

401(k) Match

6% 401k match offered to employees

On-site Lunch

Lunch provided on-site for employees

Paid Time Off

15 vacation days and 6 sick days provided annually

Stock Options

Stock options granted to employees, vested once a year

View Summit Therapeutics's employee benefits
Claim this profileSummit Therapeutics logoST

Summit Therapeutics

View company profile

Similar remote jobs

Here are other jobs you might want to apply for.

View all remote jobs

5 remote jobs at Summit Therapeutics

Explore the variety of open remote roles at Summit Therapeutics, offering flexible work options across multiple disciplines and skill levels.

View all jobs at Summit Therapeutics

Remote companies like Summit Therapeutics

Find your next opportunity by exploring profiles of companies that are similar to Summit Therapeutics. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan